3MR-83697-85794
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 018 / MA
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-11
Registered in v-safe
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-23
-
2021-04-30
Dose 2 — Pfizer-BioNTech
- 2021-04-30
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache · Be unable to workAdult check-in
- 2021-05-03
- 2021-05-04
- 2021-05-05
-
2022-04-30
Survey response — 12 months, dose 2MedDRA: COVID-19, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: I had Covid · Healthcare visit (other): NoneMedDRA releases: 2024-11 · check-in free text available
-
2022-04-30
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-05-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-30 | Successful 2022-05-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release